AMRC fell more than 10% on Tuesday — its worst single session in months — creating a sharp divergence between a bearish analyst call and a founder who has been buying stock almost every week.
The session loss arrived alongside a Baird downgrade. Analyst Ben Kallo cut his rating to Neutral from Outperform and trimmed his target to $32 from $36 — a meaningful pivot from a firm that had held a positive view through much of the year. The downgrade adds weight to a stock already carrying 12.2% of its free float short — a genuinely elevated level for a company this size. That combination of fresh analyst caution and a high short base gives the Tuesday selloff more staying power than a simple bad-news day.
The positioning picture is, in some ways, less alarming than the headline short interest figure suggests. Short interest has edged up about 2.3% over the past week to roughly 4.24 million shares, but at a borrow cost of just 0.58% — the lowest in at least six weeks and down more than 20% on the week — there is no sign that the short community is scrambling for stock. Availability remains ample at 343%, meaning roughly 3.4 shares sit available to borrow for every one already lent out, well off the year's tightest level of 243% seen in late July. Options traders are not particularly defensive either: the put/call ratio of 0.23 is barely above its 20-day average and nowhere near the 52-week high of 0.66. Short interest tells a high-but-stable story, not a pressure-building one.
The Street remains split, and Baird's move crystallises the debate. After last month's Q2 earnings print — which sent the stock up 33% in a single session — a cluster of analysts raised targets: BNP Paribas upgraded to Outperform with a $40 target, and Canaccord Genuity pushed its Buy target to $62. The mean price target among analysts is $43.90, against a current price of $25.49, implying substantial upside on the consensus view. Bulls point to the $10 billion backlog, expanding Energy Assets revenues, and a forward EPS momentum score ranked in the 85th percentile. Bears, with Baird now among them, focus on margin pressure, single-segment revenue concentration, and execution risk on the RNG side. The analyst recommendation divergence factor score sits in the 92nd percentile — a sign that the gap between bulls and bears is unusually wide even by historical standards.
The most pointed signal this week is what the founder is doing. George Sakellaris — who controls 38% of shares outstanding and serves as Chairman, President, and CEO — bought stock on August 7, August 10, and again on August 11, spending a combined $181,000 in open-market purchases at prices between $25.07 and $25.95. A director separately bought nearly 40,000 shares on August 10 for close to $1 million. The 90-day insider net across all transactions is positive at roughly $2 million and 73,000 shares. Founders who buy repeatedly in the open market around the $25 level are making an observable statement about where they think value sits — regardless of the signal Baird is sending at the same moment.
Millennium Management is worth noting on the institutional side. The fund added over 1.5 million shares in its most recent reported period, now holding 3.4% of the company. That is a meaningful new position from an active manager with a reputation for shorter-duration trades — worth monitoring for any reversal if the stock stays under pressure.
The next earnings event is scheduled for November 4. That leaves two and a half months for the narrative to stabilise — whether Tuesday's drop reflects a genuine re-rating or a post-earnings hangover being amplified by the Baird downgrade is the central question worth tracking into autumn.
See the live data behind this article on ORTEX.
Open AMRC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
